Medications

FDA: Purveyors of phony botox targeting U.S. practices

(HealthDay)—Medical practices that purchase Botox may unwittingly be purchasing a fraudulent product not approved by the U.S. Food and Drug Administration for sale in the United States, according to an April 26 drug safety ...

Medications

DEA settles Walgreens painkiller case for $80M

The U.S. Drug Enforcement Administration has reached an $80 million civil settlement with the Walgreens pharmacy chain over violations of rules governing the distribution of powerful prescription painkillers.

page 1 from 2